Non-coding RNA networks in cancer

E Anastasiadou, LS Jacob, FJ Slack - Nature Reviews Cancer, 2018 - nature.com
Thousands of unique non-coding RNA (ncRNA) sequences exist within cells. Work from the
past decade has altered our perception of ncRNAs from'junk'transcriptional products to …

[HTML][HTML] Mechanisms of receptor tyrosine kinase activation in cancer

Z Du, CM Lovly - Molecular cancer, 2018 - Springer
Receptor tyrosine kinases (RTKs) play an important role in a variety of cellular processes
including growth, motility, differentiation, and metabolism. As such, dysregulation of RTK …

[HTML][HTML] Oncogenic role of fusion-circRNAs derived from cancer-associated chromosomal translocations

J Guarnerio, M Bezzi, JC Jeong, SV Paffenholz, K Berry… - Cell, 2016 - cell.com
Chromosomal translocations encode oncogenic fusion proteins that have been proven to be
causally involved in tumorigenesis. Our understanding of whether such genomic alterations …

[HTML][HTML] Ceritinib in ALK-Rearranged Non–Small-Cell Lung Cancer

AT Shaw, DW Kim, R Mehra, DSW Tan… - … England Journal of …, 2014 - Mass Medical Soc
Background Non–small-cell lung cancer (NSCLC) harboring the anaplastic lymphoma
kinase gene (ALK) rearrangement is sensitive to the ALK inhibitor crizotinib, but resistance …

[HTML][HTML] Molecular epidemiology of the main druggable genetic alterations in non-small cell lung cancer

SS Fois, P Paliogiannis, A Zinellu, AG Fois… - International journal of …, 2021 - mdpi.com
Lung cancer is the leading cause of death for malignancy worldwide. Its molecular profiling
has enriched our understanding of cancer initiation and progression and has become …

[HTML][HTML] Circles reshaping the RNA world: from waste to treasure

J Liu, T Liu, X Wang, A He - Molecular cancer, 2017 - Springer
A new type of RNAs was identified from genes traditionally thought to express messenger or
linear ncRNA (noncoding RNA) only. They were subsequently named as circRNAs (circular …

Mechanisms of Resistance to Crizotinib in Patients with ALK Gene Rearranged Non–Small Cell Lung Cancer

RC Doebele, AB Pilling, DL Aisner, TG Kutateladze… - Clinical cancer …, 2012 - AACR
Purpose: Patients with anaplastic lymphoma kinase (ALK) gene rearrangements often
manifest dramatic responses to crizotinib, a small-molecule ALK inhibitor. Unfortunately, not …

ALK Rearrangements Are Mutually Exclusive with Mutations in EGFR or KRAS: An Analysis of 1,683 Patients with Non–Small Cell Lung Cancer

JF Gainor, AM Varghese, SHI Ou, S Kabraji… - Clinical cancer …, 2013 - AACR
Purpose: Anaplastic lymphoma kinase (ALK) gene rearrangements define a distinct
molecular subset of non–small cell lung cancer (NSCLC). Recently, several case reports …

[HTML][HTML] Comprehensive genomic and immunological characterization of Chinese non-small cell lung cancer patients

XC Zhang, J Wang, GG Shao, Q Wang, X Qu… - Nature …, 2019 - nature.com
Deep understanding of the genomic and immunological differences between Chinese and
Western lung cancer patients is of great importance for target therapy selection and …

Lung cancer mutation profile of EGFR, ALK, and KRAS: Meta-analysis and comparison of never and ever smokers

AM Chapman, KY Sun, P Ruestow, DM Cowan… - Lung cancer, 2016 - Elsevier
Lung cancer is the leading cause of cancer-related mortality. While the majority of lung
cancers are associated with tobacco smoke, approximately 10–15% of US lung cancers …